個股熱度排行 | 8月1日港股盤前
根據uSMART輿情監測數據，週末期間，市場關注指數最高的5只股票是阿裏巴巴-SW、中國恆大、復星醫藥、中國同輻、中芯國際。
8月1日—港股關注排行TOP5
阿裏巴巴-SW
關注度第一爲阿裏巴巴-SW，該股上個交易日收盤下跌6.10%，報於93.10港元。近5個交易日累計下跌8.81%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
阿裏巴巴︰遵守適用法律法規、努力保持紐交所、港交所兩地上市地位 日前遭列入「預定摘牌名單」
阿裏巴巴8.4公佈6月底止季績 受累疫情收入料倒退1%、上市以來首見負增長
中國恆大
關注度第二爲中國恆大，該股上個交易日收盤上漲8.55%，報於1.65港元。近5個交易日累計上漲13.01%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
恆大：冀年內公佈重組方案 續與境外債權人溝通 上半年合約銷售仍有123億人幣
中國恆大力爭年內落實債務重組方案 恆馳5汽車上月預售
復星醫藥
關注度第三爲復星醫藥，該股上個交易日收盤下跌3.57%，報於28.40港元。近5個交易日累計下跌7.94%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
復星醫藥：擬以4.12億元增持杏脈科技部分股權、利於拓展在數智醫療領域的佈局
復星醫藥：擬以4.02億元受讓上海復拓49%股權
中國同輻
關注度第四爲中國同輻，該股上個交易日收盤持平，報於18.22港元。近5個交易日累計下跌3.19%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
中國同輻：張慶軍辭任公司監事
中國同輻建議聘任信永中和擔任2022年度境外核數師
中芯國際
關注度第五爲中芯國際，該股上個交易日收盤下跌2.15%，報於16.38港元。近5個交易日累計下跌3.08%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
中芯國際因行使根據2014以股支薪獎勵計劃發行9750股
中芯國際、恩智浦、聯想、谷歌、大陸，他們瓜分了摩託羅拉
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
